Novartis: 1999 starts on loss

Over the first three months 1999 the giant of pharmaceutics Novartis has recorded a billing of 9480 billions lire, highlighting a decrease of 1% with respect to the first three months of last year. The loss is mainly due to the agri-business sector (-10%).